
|Articles|June 15, 2003
Subconjunctival botulinum toxin helps treat eyelid retraction
Author(s)Cheryl Guttman
London-Subconjunctival injection of botulinum toxin type A (Botox, Allergan) can offer an effective treatment for upper eyelid retraction associated with thyroid eye dis-ease, said Jimmy M. Uddin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
Preclinical study suggests synaptic regeneration may offer new pathway to treat glaucoma
3
AAO 2025: Arshad M. Khanani, MD, highlights 3-year results from the GATHER2 open-label extension trial
4
AAO 2025: Trial demonstrates safety and efficacy of epithelium-on cross linking
5